{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,6]],"date-time":"2025-08-06T12:28:58Z","timestamp":1754483338653,"version":"3.27.0"},"reference-count":46,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T00:00:00Z","timestamp":1760832000000},"content-version":"am","delay-in-days":413,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Therapies"],"published-print":{"date-parts":[[2024,9]]},"DOI":"10.1016\/j.therap.2024.02.001","type":"journal-article","created":{"date-parts":[[2024,2,24]],"date-time":"2024-02-24T16:18:22Z","timestamp":1708791502000},"page":"565-575","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Medication-overuse headache: A pharmacovigilance study in France"],"prefix":"10.1016","volume":"79","author":[{"given":"Mohamad Houssam","family":"Al Balkhi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julien","family":"Moragny","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sol\u00e8ne M.","family":"Laville","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sophie","family":"Liabeuf","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pauline-Eva","family":"Pecquet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Benjamin","family":"Batteux","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cosette","family":"Le Souder","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Florelle","family":"Bellet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Val\u00e9rie","family":"Gras","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kamel","family":"Masmoudi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.therap.2024.02.001_bib0235","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1177\/0333102417738202","article-title":"The International Classification of Headache Disorders, 3rd edition","volume":"38","year":"2018","journal-title":"Cephalalgia"},{"key":"10.1016\/j.therap.2024.02.001_bib0240","doi-asserted-by":"crossref","first-page":"1408","DOI":"10.3390\/brainsci13101408","article-title":"A descriptive review of medication-overuse headache: from pathophysiology to the comorbidities","volume":"13","author":"Ljubisavljevic","year":"2023","journal-title":"Brain Sci"},{"key":"10.1016\/j.therap.2024.02.001_bib0245","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1186\/s10194-018-0875-x","article-title":"Medication-overuse headache: a widely recognized entity amidst ongoing debate","volume":"19","author":"Vandenbussche","year":"2018","journal-title":"J Headache Pain"},{"key":"10.1016\/j.therap.2024.02.001_bib0250","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1055\/s-0038-1646946","article-title":"The global burden of headache","volume":"38","author":"Saylor","year":"2018","journal-title":"Semin Neurol"},{"key":"10.1016\/j.therap.2024.02.001_bib0255","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1111\/j.1468-1331.2011.03612.x","article-title":"The cost of headache disorders in Europe: the Eurolight project","volume":"19","author":"Linde","year":"2012","journal-title":"Eur J Neurol"},{"key":"10.1016\/j.therap.2024.02.001_bib0260","doi-asserted-by":"crossref","first-page":"1194134","DOI":"10.3389\/fpain.2023.1194134","article-title":"Medication overuse headache: a review of current evidence and management strategies","volume":"4","author":"Kebede","year":"2023","journal-title":"Front Pain Res (Lausanne)"},{"key":"10.1016\/j.therap.2024.02.001_bib0265","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.1111\/j.1526-4610.2010.01755.x","article-title":"What is the role of dependence-related behavior in medication-overuse headache?","volume":"50","author":"Radat","year":"2010","journal-title":"Headache"},{"key":"10.1016\/j.therap.2024.02.001_bib0270","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1111\/j.1468-2982.2006.01198.x","article-title":"Medication overuse headache: type I and type II","volume":"26","author":"Saper","year":"2006","journal-title":"Cephalalgia"},{"key":"10.1016\/j.therap.2024.02.001_bib0275","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.1111\/j.1526-4610.2010.01711.x","article-title":"Increased prevalence of sleep disorders in chronic headache: a case-control study","volume":"50","author":"Sancisi","year":"2010","journal-title":"Headache"},{"key":"10.1016\/j.therap.2024.02.001_bib0280","doi-asserted-by":"crossref","first-page":"1694","DOI":"10.1212\/WNL.57.9.1694","article-title":"Clinical features of withdrawal headache following overuse of triptans and other headache drugs","volume":"57","author":"Katsarava","year":"2001","journal-title":"Neurology"},{"key":"10.1016\/j.therap.2024.02.001_bib0285","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.pain.2005.09.034","article-title":"Does medication overuse headache represent a behavior of dependence?","volume":"119","author":"Fuh","year":"2005","journal-title":"Pain"},{"key":"10.1016\/j.therap.2024.02.001_bib0290","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1136\/jnnp.2008.168864","article-title":"The severity of dependence scale detects people with medication overuse: the Akershus study of chronic headache","volume":"80","author":"Grande","year":"2009","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.therap.2024.02.001_bib0295","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1186\/s10194-021-01224-8","article-title":"Medication overuse and drug addiction: a narrative review from addiction perspective","volume":"22","author":"Takahashi","year":"2021","journal-title":"J Headache Pain"},{"key":"10.1016\/j.therap.2024.02.001_bib0300","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.pain.2011.08.018","article-title":"Risk factors for medication-overuse headache: an 11-year follow-up study. The Nord-Tr\u00f8ndelag health studies","volume":"153","author":"Hagen","year":"2012","journal-title":"Pain"},{"key":"10.1016\/j.therap.2024.02.001_bib0305","series-title":"Statpearls","article-title":"Medication-overuse headache","author":"Fischer","year":"2022"},{"key":"10.1016\/j.therap.2024.02.001_bib0310","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1186\/1471-2377-10-126","article-title":"Abnormal cortical responses to somatosensory stimulation in medication-overuse headache","volume":"10","author":"Coppola","year":"2010","journal-title":"BMC Neurol"},{"key":"10.1016\/j.therap.2024.02.001_bib0315","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1007\/s10194-012-0479-9","article-title":"Depression and risk of transformation of episodic to chronic migraine","volume":"13","author":"Ashina","year":"2012","journal-title":"J Headache Pain"},{"key":"10.1016\/j.therap.2024.02.001_bib0320","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1007\/s10072-018-3390-6","article-title":"Psychopathological profile of medication overuse headache patients, drug assumption and degree of disability","volume":"39","author":"Migliore","year":"2018","journal-title":"Neurol Sci"},{"key":"10.1016\/j.therap.2024.02.001_bib0325","doi-asserted-by":"crossref","first-page":"1874078","DOI":"10.1155\/2019\/1874078","article-title":"Personality and personality disorders in medication-overuse headache: a controlled study by SWAP-200","volume":"2019","author":"Galli","year":"2019","journal-title":"Pain Res Manag"},{"year":"2017","series-title":"Guideline on good pharmacovigilance practices (GVP)\u00a0\u2013\u00a0Module VI (Rev 2) EMA\/873138\/2011 Rev 2","key":"10.1016\/j.therap.2024.02.001_bib0330"},{"key":"10.1016\/j.therap.2024.02.001_bib0335","first-page":"111","article-title":"Imputation of the unexpected or toxic effects of drugs. Actualization of the method used in France","volume":"40","author":"B\u00e9gaud","year":"1985","journal-title":"Therapie"},{"key":"10.1016\/j.therap.2024.02.001_bib0340","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1007\/s40264-016-0444-7","article-title":"Adverse-drug-reaction-related hospitalisations in developed and developing countries: a review of prevalence and contributing factors","volume":"39","author":"Angamo","year":"2016","journal-title":"Drug Saf"},{"year":"2021","series-title":"Introductory Guide MedDRA Version 24.1","key":"10.1016\/j.therap.2024.02.001_bib0345"},{"year":"2023","series-title":"ATC\/DDD Index","key":"10.1016\/j.therap.2024.02.001_bib0350"},{"key":"10.1016\/j.therap.2024.02.001_bib0355","doi-asserted-by":"crossref","first-page":"517","DOI":"10.2515\/therapie\/2011073","article-title":"R\u00e9actualisation de la m\u00e9thode fran\u00e7aise d\u2019imputabilit\u00e9 des effets ind\u00e9sirables des m\u00e9dicaments","volume":"66","author":"Arimone","year":"2011","journal-title":"Therapie"},{"key":"10.1016\/j.therap.2024.02.001_bib0360","unstructured":"Health Action International. Direct patient reporting in the European union a snapshot of reporting systems in seven Member States. https:\/\/haiweb.org\/wp-content\/uploads\/2015\/09\/Direct-Patient-Reporting-in-the-EU.pdf [Accessed 22 February 2024 (18 pp.)]."},{"year":"2012","series-title":"The EPF guidance for patient organisations on the new EU pharmacovigilance legislation arises from the EPF 2012 Work Programme","key":"10.1016\/j.therap.2024.02.001_bib0365"},{"key":"10.1016\/j.therap.2024.02.001_bib0370","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1111\/fcp.12343","article-title":"Adverse drug reactions of analgesic medicines: analysis of the Romanian pharmacovigilance database","volume":"32","author":"Cazacu","year":"2018","journal-title":"Fundam Clin Pharmacol"},{"key":"10.1016\/j.therap.2024.02.001_bib0375","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1007\/s00228-012-1321-7","article-title":"Underreporting in pharmacovigilance: an intervention for Italian GPs (Emilia-Romagna region)","volume":"69","author":"Biagi","year":"2013","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1016\/j.therap.2024.02.001_bib0380","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1080\/14740338.2017.1323867","article-title":"Empirical estimation of under-reporting in the U.S. Food and Drug Administration Adverse Event Reporting System (FAERS)","volume":"16","author":"Alatawi","year":"2017","journal-title":"Exp Opin Drug Saf"},{"key":"10.1016\/j.therap.2024.02.001_bib0385","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1177\/0333102413512033","article-title":"Definitions of medication-overuse headache in population-based studies and their implications on prevalence estimates: a systematic review","volume":"34","author":"Westergaard","year":"2014","journal-title":"Cephalalgia"},{"key":"10.1016\/j.therap.2024.02.001_bib0390","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1177\/2042098614522683","article-title":"Medication-overuse headache: epidemiology, diagnosis and treatment","volume":"5","author":"Kristoffersen","year":"2014","journal-title":"Ther Adv Drug Saf"},{"key":"10.1016\/j.therap.2024.02.001_bib0395","doi-asserted-by":"crossref","first-page":"5729","DOI":"10.1007\/s10072-022-06178-6","article-title":"Sex and gender differences in migraines: a narrative review","volume":"43","author":"Rossi","year":"2022","journal-title":"Neurol Sci"},{"key":"10.1016\/j.therap.2024.02.001_bib0400","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1177\/0333102409357958","article-title":"Headache characteristics and chronification of migraine and tension-type headache: a population-based study","volume":"30","author":"Ashina","year":"2010","journal-title":"Cephalalgia"},{"key":"10.1016\/j.therap.2024.02.001_bib0405","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1111\/j.1526-4610.2009.01395.x","article-title":"Use and overuse of antimigraine drugs by pharmacy personnel in France: COTA survey: research submission","volume":"49","author":"Donnet","year":"2009","journal-title":"Headache"},{"key":"10.1016\/j.therap.2024.02.001_bib0410","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1111\/j.1526-4610.2008.01217.x","article-title":"Acute migraine medications and evolution from episodic to chronic migraine: a longitudinal population-based study","volume":"48","author":"Bigal","year":"2008","journal-title":"Headache"},{"key":"10.1016\/j.therap.2024.02.001_bib0415","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1111\/j.1468-2982.2009.01906.x","article-title":"Prevalence of chronic migraine and medication overuse headache in Germany\u00a0\u2014\u00a0the German DMKG headache study","volume":"30","author":"Straube","year":"2010","journal-title":"Cephalalgia"},{"key":"10.1016\/j.therap.2024.02.001_bib0420","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1177\/0333102411410082","article-title":"Epidemiology of medication overuse headache in the general Swedish population","volume":"31","author":"Jonsson","year":"2011","journal-title":"Cephalalgia"},{"key":"10.1016\/j.therap.2024.02.001_bib0425","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1186\/s10194-016-0696-8","article-title":"Risk of medication overuse headache across classes of treatments for acute migraine","volume":"17","author":"Thorlund","year":"2016","journal-title":"J Headache Pain"},{"key":"10.1016\/j.therap.2024.02.001_bib0430","doi-asserted-by":"crossref","first-page":"1821","DOI":"10.1212\/01.wnl.0000335946.53860.1d","article-title":"Excessive acute migraine medication use and migraine progression","volume":"71","author":"Bigal","year":"2008","journal-title":"Neurology"},{"key":"10.1016\/j.therap.2024.02.001_bib0435","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1111\/ene.12794","article-title":"Psychopathological comorbidities in medication-overuse headache: a multicentre clinical study","volume":"23","author":"Sarchielli","year":"2016","journal-title":"Eur J Neurol"},{"key":"10.1016\/j.therap.2024.02.001_bib0440","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1177\/0333102413477737","article-title":"Factors associated with a negative outcome of medication-overuse headache: a 3-year follow-up (the \u2018CARE\u2019 protocol)","volume":"33","author":"Sances","year":"2013","journal-title":"Cephalalgia"},{"key":"10.1016\/j.therap.2024.02.001_bib0445","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1177\/0333102413515338","article-title":"Disability, anxiety and depression associated with medication-overuse headache can be considerably reduced by detoxification and prophylactic treatment. Results from a multicentre, multinational study (COMOESTAS project)","volume":"34","author":"Bendtsen","year":"2014","journal-title":"Cephalalgia"},{"key":"10.1016\/j.therap.2024.02.001_bib0450","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1111\/j.1526-4610.2008.01257.x","article-title":"Family history for chronic headache and drug overuse as a risk factor for headache chronification","volume":"49","author":"Cevoli","year":"2009","journal-title":"Headache"},{"key":"10.1016\/j.therap.2024.02.001_bib0455","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.1111\/j.1526-4610.2011.01978.x","article-title":"Differences in the personality profile of medication-overuse headache sufferers and drug addict patients: a comparative study using MMPI-2","volume":"51","author":"Galli","year":"2011","journal-title":"Headache"},{"key":"10.1016\/j.therap.2024.02.001_bib0460","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1111\/j.1468-2982.2004.00691.x","article-title":"Transformed migraine and Medication overuse in a tertiary headache centre\u00a0\u2014\u00a0Clinical characteristics and treatment outcomes","volume":"24","author":"Bigal","year":"2004","journal-title":"Cephalalgia"}],"container-title":["Therapies"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0040595724000325?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0040595724000325?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,10,19]],"date-time":"2024-10-19T06:53:51Z","timestamp":1729320831000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0040595724000325"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9]]},"references-count":46,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2024,9]]}},"alternative-id":["S0040595724000325"],"URL":"https:\/\/doi.org\/10.1016\/j.therap.2024.02.001","relation":{},"ISSN":["0040-5957"],"issn-type":[{"type":"print","value":"0040-5957"}],"subject":[],"published":{"date-parts":[[2024,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Medication-overuse headache: A pharmacovigilance study in France","name":"articletitle","label":"Article Title"},{"value":"Therapies","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.therap.2024.02.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Soci\u00e9t\u00e9 fran\u00e7aise de pharmacologie et de th\u00e9rapeutique. Published by Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}